TITLE:
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients

CONDITION:
Open-angle Glaucoma

INTERVENTION:
AL-12182 0.003% Ophthalmic Solution

SUMMARY:

      The purpose of this study is to determine the safety and IOP-lowering ability of a glaucoma
      therapy in patients with open-angle glaucoma or ocular hypertension.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  18 years or older.

          -  Diagnosis of open-angle glaucoma or ocular hypertension.

          -  LogMAR visual acuity not worse than 0.6.

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Clinically relevant ophthalmic or systemic conditions.

          -  Other protocol-defined exclusion criteria may apply.
      
